KPTI vs AMGN: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Amgen Inc in 2026
KPTI
Karyopharm Therapeutics Inc
$8.45
AMGN
Amgen Inc
$350.95
Key Metrics Comparison
| Metric | KPTI | AMGN | Winner |
|---|---|---|---|
| Market Cap | $186.66M | $188.58B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | 0.1% | 0.1% | KPTI |
| Gross Margin | 9.9% | 70.8% | AMGN |
Analyze KPTI
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or AMGN a better investment?
Comparing KPTI and AMGN: Karyopharm Therapeutics Inc has a market cap of $186.66M while Amgen Inc has $188.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and AMGN?
KPTI (Karyopharm Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or AMGN?
KPTI has higher revenue growth at 0.1% vs 0.1% for AMGN.
Which company is more profitable: KPTI or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 9.9% for KPTI.
Which is the larger company: KPTI or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.58B compared to $186.66M for KPTI.
Should I buy KPTI or AMGN in 2026?
Both KPTI and AMGN have investment merit. KPTI trades at $8.45 while AMGN trades at $350.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and AMGN stock?
Key differences: Market Cap ($186.66M vs $188.58B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (9.9% vs 70.8%).